ArticleTrials2022

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial.

J M McGree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.